Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Descriptive Evalaution of Characteristics of Patients Diagnosed with Relapsing Remitting Multiple Sclerosis and Taking Disease Modifying Agents.
A Cost-Effectiveness Analysis of Fingolimod Versus Dimethyl Fumarate As A Second-Line Disease Modifying Treatment In Patients With Highly Active Relapsing-Remitting Multiple Sclerosis.
Nurse led telephone assessment of expanded disability status scale assessment in MS patients at high levels of disability.
Seroprevalence of NMO-IgG among patients with neuromyelitis optica and opticospinal multiple sclerosis.
Interactions between Neutrophils, Th17 Cells, and Chemokines during the Initiation of Experimental Model of Multiple Sclerosis.
MAG, myelin and overcoming growth inhibition in the CNS.
Costs Associated With Patients Diagnosed With Relapsing Remitting Multiple Sclerosis Taking Once Daily Fingolimod Capsules In The United States.
Cost of Drug-Related Monitoring Requirements for Glatiramer Acetate and Other Multiple Sclerosis Disease-Modifying Therapies (Dmts).
Kainic Acid-Induced Excitotoxicity Experimental Model: Protective Merits of Natural Products and Plant Extracts.
Dopamine characteristics in different rat genotypes: the relation to absence epilepsy.
[Production of peroxide hydrogen in Chattonella ovata Hong Kong strain].
Adipose-derived mesenchymal stem cells modulate the immune response in chronic experimental autoimmune encephalomyelitis model.
Editorial: Single membrane channels formed by connexins or pannexins: focus on the nervous system.
The Montreal Cognitive Assessment (MoCA) as a screening test for cognitive dysfunction in multiple sclerosis.
Antibody therapies in CNS diseases.
Lupus erythematosus profundus masquerading as idiopathic orbital inflammatory syndrome.
Mechanisms and time course of neuronal degeneration in experimental autoimmune encephalomyelitis.
Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.
[Acute disseminated encephalomyelitis (ADEM)].
Cost-Utility Analysis of Delayed-Release Dimethyl Fumerate For The Treatment of Relapsing-Remitting Multiple Sclerosis In Portugal.
Clinical implications of neuroplasticity - the role of rehabilitation in multiple sclerosis.
CMTX Disorder and CamKinase.
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches.
Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes.

Pages